Investors

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

Shuang Yang, Scientist, China

Second quarter 2024 results

Second quarter 2024 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

Thursday July 25, 2024
14:30 - 16:00 CET (8:30am – 10am EST)

Discover more

Upcoming events

15Aug

2024

TD Cowen Hot Wheels Bus Tour

11:45 - 12:45 EST

Broker Conference

4Sep

2024

J.P. Morgan European Healthcare CEO Call Series

15:00 - 16:00 CEST

Broker Conference

6Sep

2024

Morgan Stanley 22nd Annual Global Healthcare Conference

08:30 - 14:00 EST

Broker Conference

All our events

Press releases

July 25, 2024
Press Release: Online availability of Sanofi’s half-year financial report for 2024
July 25, 2024
Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
July 17, 2024
Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

2023 20-F

Presenting our 2023 FORM 20-F.

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com